Thapanee Somboon (Cleveland Clinic, OH) talks us through the key findings of her two presentations, which focused on the prevalence of high risk obstructive sleep apnea and insomnia in neurological populations (abstract available here) and the performance of sleep apnea screening tools in former professional athletes (abstract available here).
1. How prevalent are obstructive sleep apnea and insomnia in neurological populations? (0:11)
2. How effective are the STOP score and insomnia severity index in assessing obstructive sleep apnea and insomnia in neurological populations? (0:58)
3. What is the impact of high STOP score and insomnia severity index on neurological disease outcomes? (1:39)
4. What are the advantages and the limitations of home sleep apnea tests (HSAT) in assessing obstructive sleep apnea? (3:10)
5. What were the findings of your study comparing the STOP-BANG questionnaire and HSAT in professional athletes? (3:55)
To view full article click here.
Speaker disclosure: Thapanee Somboon has nothing to disclose in relation to this video interview.
Filmed at the American Academy of Neurology (AAN) Annual Meeting 2018, Los Angeles, CA, US, April 2018.
Share this Video
Related Videos In Neurometabolic Disease
Tahseen Mozaffar: PROPEL Study Results Investigating the use of AT-GAA for the Treatment of Late-onset Pompe Disease
touchNEUROLOGY caught up with Tahseen Mozaffar (University California, Irvine, CA, USA) to discuss the results from the PROPEL study (NCT03729362) investigating the use of AT-GAA for the treatment of late-onset Pompe disease. Questions: Could you tell us a little about late onset Pompe disease and the unmet needs in its treatment? (0:15) What is AT-GAA […]
Antonio Federico, EAN 2018 – Effects of migration on the pathophysiology of neurological conditions
Antonio Federico (EAN Scientific Committee Chair; Professor, Clinical Neurology and Neurometabolic Diseases, University of Siena, Italy) describes the impact increased migration has had on the pathophysiology of neurological conditions and the need to increase awareness of this amongst neurologists. Questions 1. What has the increased migration of European people taught us about the pathophysiology of […]
Antonio Federico, EAN 2018 – Involvement of the EAN in rare neurological diseases
Antonio Federico (EAN Scientific Committee Chair; Professor, Clinical Neurology and Neurometabolic Diseases, University of Siena, Italy) discusses the unique challenges that rare neurological diseases bring and how the EAN have a Task Force focused on this important area. Questions 1. Could you tell us a little about the Task Force within the EAN that is […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!